IGC
IGC
AMEX · Pharmaceuticals

Igc Pharma Inc

$0.29
+0.01 (+5.22%)
As of Mar 22, 10:54 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.64M
Net Income
-9,197,916
Gross Margin
48.7%
Profit Margin
-560.3%
Rev Growth
+47.0%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.7% 48.7% 57.7% 57.7%
Operating Margin -585.8% -527.3% 15.4% 17.4%
Profit Margin -560.3% -532.3% 15.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.64M 1.12M 13.95M 13.36M
Gross Profit 798.7K 543.3K 8.05M 7.71M
Operating Income -9,607,863 -5,881,564 2.14M 2.33M
Net Income -9,197,916 -5,630,611 2.16M 1.76M
Gross Margin 48.7% 48.7% 57.7% 57.7%
Operating Margin -585.8% -527.3% 15.4% 17.4%
Profit Margin -560.3% -532.3% 15.5% 13.2%
Rev Growth +47.0% +47.0% +17.1% -6.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 284.1K 284.1K 9.96M 10.38M
Total Equity 13.15M 13.15M 19.20M 17.06M
D/E Ratio 0.02 0.02 0.52 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,397,668 -5,426,326 3.52M 3.64M
Free Cash Flow 2.06M 1.63M